Crispr Therapeutics shares owned by Elkhorn Partners Limited Partnership
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Elkhorn Partners Limited Partnership
from 13F filings
Historical chart of Elkhorn Partners Limited Partnership investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Elkhorn Partners Limited Partnership consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Crispr Therapeutics by Elkhorn Partners Limited Partnership
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $143k | 2.2k | 64.81 |
| 2025-06-30 | $195k | 4.0k | 48.64 |
| 2025-03-31 | $143k | 4.2k | 34.05 |
| 2024-12-31 | $150k | 3.8k | 39.47 |
| 2024-09-30 | $146k | 3.1k | 47.10 |
| 2024-06-30 | $54k | 1.0k | 54.00 |
| 2023-09-30 | $11k | 250 | 44.00 |
| 2023-06-30 | $2.0k | 30 | 66.67 |
| 2023-03-31 | $27k | 600 | 45.00 |
| 2022-12-31 | $55k | 1.4k | 40.74 |
| 2022-03-31 | $35k | 550 | 63.64 |
| 2021-12-31 | $27k | 350 | 77.14 |
| 2021-09-30 | $14k | 125 | 112.00 |
| 2021-06-30 | $20k | 125 | 160.00 |
More positions owned by Elkhorn Partners Limited Partnership
View all positions for Elkhorn Partners Limited Partnership